Advertisement

Research Gaps on Use of Opioids for Chronic Noncancer Pain: Findings From a Review of the Evidence for an American Pain Society and American Academy of Pain Medicine Clinical Practice Guideline

      Abstract

      Chronic noncancer pain is common and use of opioids is increasing. Previously published guidelines on use of opioids for chronic noncancer pain have been based primarily on expert consensus due to lack of strong evidence. We conducted searches on Ovid MEDLINE and the Cochrane databases through July 2008 to identify studies that addressed one or more of 37 Key Questions that a multidisciplinary expert panel identified as important to be answered to generate evidence-based recommendations on the use of opioids for chronic noncancer pain. A total of 14 systematic reviews, 38 randomized trials not included in a previously published systematic review, and 13 other studies met inclusion criteria. Almost all of the randomized trials of opioids for chronic noncancer pain were short-term efficacy studies. Critical research gaps on use of opioids for chronic noncancer pain include: lack of effectiveness studies on long-term benefits and harms of opioids (including drug abuse, addiction, and diversion); insufficient evidence to draw strong conclusions about optimal approaches to risk stratification, monitoring, or initiation and titration of opioid therapy; and lack of evidence on the utility of informed consent and opioid management plans, the utility of opioid rotation, the benefits and harms specific to methadone or higher doses of opioids, and treatment of patients with chronic noncancer pain at higher risk for drug abuse or misuse.

      Perspective

      Currently, clinical decisions regarding the use of opioids for chronic noncancer pain need to be made based on weak evidence. Research funding priorities need to be set to address these critical research needs if the care of patients with chronic noncancer pain is to improve.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal

      Subscribe:

      Subscribe to The Journal of Pain
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Ackerman S.J.
        • Knight T.
        • Schein J.
        • Carter C.
        • Staats P.
        Risk of constipation in patients prescribed fentanyl transdermal system or oxycodone hydrochloride controlled-release in a California Medicaid population.
        Consult Pharm. 2004; 19: 118-132
        • Adams L.L.
        • Gatchel R.J.
        • Robinson R.C.
        • Polatin P.
        • Gajraj N.
        • Deschner M.
        • Noe C.
        Development of a self-report screening instrument for assessing potential opioid medication misuse in chronic pain patients.
        J Pain Symptom Manage. 2004; 27: 440-459
        • Akbik H.
        • Butler S.F.
        • Budman S.H.
        • Fernandez K.
        • Katz N.P.
        • Jamison R.N.
        Validation and clinical application of the Screener and Opioid Assessment for Patients with Pain (SOAPP).
        J Pain Symptom Manage. 2006; 32: 287-293
        • Allan L.
        • Richarz U.
        • Simpson K.
        • Slappendel R.
        Transdermal fentanyl versus sustained release oral morphine in strong-opioid naive patients with chronic low back pain.
        Spine. 2005; 30: 2484-2490
        • Angst M.S.
        • Clark J.D.
        Opioid-induced hyperalgesia: A qualitative systematic review.
        Anesthesiology. 2006; 104: 570-587
        • Atluri S.L.
        • Sudarshan G.
        Development of a screening tool to detect the risk of inappropriate prescription opioid use in patients with chronic pain.
        Pain Physician. 2004; 7: 333-338
        • Attal N.
        • Guirimand F.
        • Brasseur L.
        • Gaude V.
        • Chauvin M.
        • Bouhassira D.
        Effects of IV morphine in central pain: A randomized placebo-controlled study.
        Neurology. 2002; 58: 554-563
        • Babul N.
        • Provencher L.
        • Laberge F.
        • Harsanyi Z.
        • Moulin D.
        Comparative efficacy and safety of controlled-release morphine suppositories and tablets in cancer pain.
        J Clin Pharmacol. 1998; 38: 74-81
        • Ballantyne J.C.
        • Mao J.
        Opioid therapy for chronic pain.
        N Engl J Med. 2003; 349: 1943-1953
        • Beaver W.T.
        • Wallenstein S.L.
        • Houde R.W.
        • Rogers A.
        A clinical comparison of the analgesic effects of methadone and morphine administered intramuscularly, and of orally and parenterally administered methadone.
        Clin Pharmacol Ther. 1967; 8: 415-426
        • Beaver W.T.
        • Wallenstein S.L.
        • Houde R.W.
        • Rogers A.
        A clinical comparison of the effects of oral and intramuscular administration of analgesics: pentazocine and phenazocine.
        Clin Pharmacol Ther. 1968; 9: 582-597
        • Becker G.
        • Galandi D.
        • Blum H.E.
        Peripherally acting opioid antagonists in the treatment of opiate-related constipation: A systematic review.
        J Pain Symptom Manage. 2007; 34: 547-565
        • Belgrade M.J.
        • Schamber C.D.
        • Lindgren B.R.
        The DIRE score: Predicting outcomes of opioid prescribing for chronic pain.
        J Pain. 2006; 7: 671-681
        • Bombardier C.
        • Esmail R.
        • Nachemson A.L.
        the Back Review Group Editorial Board: The Cochrane Collaboration Back Review Group of Spinal Disorders.
        Spine. 1997; 22: 837-840
        • Bouter L.M.
        • Pennick V.
        • Bombardier C.
        the Editorial Board of the Back Review Group: Cochrane Back Review Group.
        Spine. 2003; 28: 1215-1218
        • British Pain Society
        Recommendations for the Appropriate Use of Opioids for Persistent Non-cancer Pain (the first revised edition).
        The British Pain Society, LondonMarch 2005
        • Butler S.F.
        • Budman S.H.
        • Fernandez K.
        • Jamison R.N.
        Validation of a screener and opioid assessment measure for patients with chronic pain.
        Pain. 2004; 112: 65-75
        • Butler S.F.
        • Budman S.H.
        • Fernandez K.C.
        • Houle B.
        • Benoit C.
        • Katz N.
        • Jamison R.N.
        Development and validation of the Current Opioid Misuse Measure.
        Pain. 2007; 130: 144-156
        • Butler S.F.
        • Fernandez K.
        • Benoit C.
        • Budman S.H.
        • Jamison R.N.
        Validation of the revised screener and opioid assessment for patients with pain (SOAPP-R).
        J Pain. 2008; 9: 360-372
        • Byas-Smith M.G.
        • Chapman S.L.
        • Reed B.
        • Cotsonis G.
        The effect of opioids on driving and psychomotor performance in patients with chronic pain.
        Clin J Pain. 2005; 21: 345-352
        • Caudill-Slosberg M.A.
        • Schwartz L.M.
        • Woloshin S.
        Office visits and analgesic prescriptions for musculoskeletal pain in US: 1980 vs 2000.
        Pain. 2004; 109: 514-519
      1. Center for Substance Abuse Treatment. Methadone-associated mortality: Report of a national assessment. May 2003

        • Office of Applied Studies, Substance Abuse and Mental Health Service Administration
        Results from the 2004 National Survey on Drug Use and Health.
        Department of Health and Human Services, Rockville, MD2005
      2. Centers for Disease Control and Prevention: Unintentional poisoning deaths–United States, 1999-2004.
        Morb Mortal Wkly Rep. 2007; 56: 93-96
        • Cepeda M.S.
        • Camargo F.
        • Zea C.
        • Valencia L.
        Tramadol for osteoarthritis.
        Cochrane Database Syst Rev. 2006; (CD005522)
        • Chou R.
        • Clark E.
        • Helfand M.
        Comparative efficacy and safety of long-acting oral opioids for chronic non-cancer pain: A systematic review.
        J Pain Symptom Manage. 2003; 26: 1026-1048
        • Chou R.
        • Fanciullo G.
        • Fine P.G.
        • Miaskowski C.
        • Passik S.
        • Portenoy P.
        Opioids for chronic noncancer pain: Prediction and identification of aberrant drug-related behaviors: A review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline.
        J Pain. 2009; 10: 131-146
        • Chou R.
        • Huffman L.
        The use of opioids for chronic non-cancer pain: Evidence review.
        American Pain Society. 2009; (in press)
        • Chugh S.S.
        • Socoteanu C.
        • Reinier K.
        • Waltz J.
        • Jui J.
        • Gunson K.
        A community-based evaluation of sudden death associated with therapeutic levels of methadone.
        Am J Med. 2008; 121: 66-71
        • Clark A.J.
        • Ahmedzai S.H.
        • Allan L.G.
        • Camacho F.
        • Horbay G.L.
        • Richarz U.
        • Simpson K.
        Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain.
        Curr Med Res Opin. 2004; 20: 1419-1428
        • Compton P.
        • Darakjian J.
        • Miotto K.
        Screening for addiction in patients with chronic pain and “problematic” substance use: Evaluation of a pilot assessment tool.
        J Pain Symptom Manage. 1998; 16: 355-363
        • Corey D.T.
        A limited functional restoration program for injured workers: A randomised trial.
        J Occup Rehabil. 1996; 6: 239-249
        • Cowan D.T.
        • Wilson-Barnett J.
        • Griffiths P.
        • Vaughan D.J.
        • Gondhia A.
        • Allan L.G.
        A randomized, double-blind, placebo-controlled, cross-over pilot study to assess the effects of long-term opioid drug consumption and subsequent abstinence in chronic noncancer pain patients receiving controlled-release morphine.
        Pain Med. 2005; 6: 113-121
        • Cruciani R.A.
        • Sekine R.
        • Homel P.
        • Lussier D.
        • Yap Y.
        • Suzuki Y.
        • Schweitzer P.
        • Yancovitz S.R.
        • Lapin J.A.
        • Shaiova L.
        • Sheu R.G.
        • Portenoy R.K.
        Measurement of QTc in patients receiving chronic methadone therapy.
        J Pain Symptom Manage. 2005; 29: 385-391
        • Daniell H.W.
        DHEAS deficiency during consumption of sustained-action prescribed opioids: Evidence for opioid-induced inhibition of adrenal androgen production.
        J Pain. 2006; 7: 901-907
        • Daniell H.W.
        Hypogonadism in men consuming sustained-action oral opioids.
        J Pain. 2002; 3: 377-384
        • Daniell H.W.
        Opioid endocrinopathy in women consuming prescribed sustained-action opioids for control of nonmalignant pain.
        J Pain. 2008; 9: 28-36
        • De Conno F.
        • Ripamonti C.
        • Saita L.
        • MacEachern T.
        • Hanson J.
        • Bruera E.
        Role of rectal route in treating cancer pain: A randomized crossover clinical trial of oral versus rectal morphine administration in opioid-naive cancer patients with pain.
        J Clin Oncol. 1995; 13: 1004-1008
        • Dellemijn P.L.
        • van Duijn H.
        • Vanneste J.A.
        Prolonged treatment with transdermal fentanyl in neuropathic pain.
        J Pain Symptom Manage. 1998; 16: 220-229
        • Deshpande A.
        • Furlan A.D.
        • Mailis-Gagnon A.
        • Atlas S.
        • Turk D.
        Opioids for chronic low-back pain.
        Cochrane Database Syst Rev. 2007; (CD004959)
        • Devulder J.
        • Richarz U.
        • Nataraja S.H.
        Impact of long-term use of opioids on quality of life in patients with chronic, non-malignant pain.
        Curr Med Res Opin. 2005; 21: 1555-1568
        • Dunbar S.A.
        • Katz N.P.
        Chronic opioid therapy for nonmalignant pain in patients with a history of substance abuse: Report of 20 cases.
        J Pain Symptom Manage. 1996; 11: 163-171
        • Edwards R.R.
        • Haythornthwaite J.A.
        • Tella P.
        • Max M.B.
        • Raja S.
        Basal heat pain thresholds predict opioid analgesia in patients with postherpetic neuralgia.
        Anesthesiology. 2006; 104: 1243-1248
        • Eisenberg E.
        • McNicol E.W.
        • Carr D.B.
        Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: Systematic review and meta-analysis of randomized controlled trials.
        JAMA. 2005; 293: 3043-3052
        • Fishbain D.A.
        • Cutler R.B.
        • Rosomoff H.L.
        • Rosomoff R.S.
        Are opioid-dependent/tolerant patients impaired in driving-related skills? A structured evidence-based review.
        J Pain Symptom Manage. 2003; 25: 559-577
        • Fishbain D.A.
        • Cutler R.B.
        • Rosomoff H.L.
        • Rosomoff R.S.
        Can patients taking opioids drive safely? A structured evidence-based review.
        J Pain Palliat Care Pharmacother. 2002; 16: 9-28
        • Fishman S.M.
        • Bandman T.B.
        • Edwards A.
        • Borsook D.
        The opioid contract in the management of chronic pain.
        J Pain Symptom Manage. 1999; 18: 27-37
        • Flor H.
        • Fydrich T.
        • Turk D.C.
        Efficacy of multidisciplinary pain treatment centers: A meta-analytic review.
        Pain. 1992; 49: 221-230
        • Franklin G.M.
        • Mai J.
        • Wickizer T.
        • Turner J.A.
        • Fulton-Kehoe D.
        • Grant L.
        Opioid dosing trends and mortality in Washington State workers' compensation, 1996-2002.
        Am J Ind Med. 2005; 48: 91-99
        • Fredheim O.M.
        • Kaasa S.
        • Dale O.
        • Klepstad P.
        • Landro N.I.
        • Borchgrevink P.C.
        Opioid switching from oral slow release morphine to oral methadone may improve pain control in chronic non-malignant pain: A nine-month follow-up study.
        Palliat Med. 2006; 20: 35-41
        • Freye E.
        • Anderson-Hillemacher A.
        • Ritzdorf I.
        • Levy J.V.
        Opioid rotation from high-dose morphine to transdermal buprenorphine (Transtec) in chronic pain patients.
        Pain Pract. 2007; 7: 123-129
        • Furlan A.D.
        • Clarke J.
        • Esmail R.
        • Sinclair S.
        • Irvin E.
        • Bombardier C.
        A critical review of reviews on the treatment of chronic low back pain.
        Spine. 2001; 26: E155-E162
        • Furlan A.D.
        • Sandoval J.A.
        • Mailis-Gagnon A.
        • Tunks E.
        Opioids for chronic noncancer pain: A meta-analysis of effectiveness and side effects.
        CMAJ. 2006; 174: 1589-1594
        • Gaertner J.
        • Radbruch L.
        • Giesecke T.
        • Gerbershagen H.
        • Petzke F.
        • Ostgathe C.
        • Elsner F.
        • Sabatowski R.
        Assessing cognition and psychomotor function under long-term treatment with controlled release oxycodone in non-cancer pain patients.
        Acta Anaesthesiol Scand. 2006; 50: 664-672
        • Galski T.
        • Williams J.B.
        • Ehle H.T.
        Effects of opioids on driving ability.
        J Pain Symptom Manage. 2000; 19: 200-208
        • Gartlehner G.
        • Hansen R.A.
        • Nissman D.
        • Lohr K.N.
        • Carey T.S.
        A simple and valid tool distinguished efficacy from effectiveness studies.
        J Clin Epidemiol. 2006; 59: 1040-1048
        • Graziotti P.
        • Goucke R.
        The use of oral opioids in patients with chronic nonmalignant pain: Management strategies.
        Med J Austr. 1997; 167: 30-34
      3. GSK, Adolor, London and Exton PU: GSK and Adolor announce preliminary results from phase 3 safety study of Alvimopan (Entereg/Entrareg). Available at: http://www.gsk.com/media/pressreleases/2007/2007_04_09_GSK1012.htm. Accessed April 9, 2007

        • Guzman J.
        • Esmail R.
        • Karjalainen K.
        • Malmivaara A.
        • Irvin E.
        • Bombardier C.
        Multidisciplinary rehabilitation for chronic low back pain: Systematic review.
        BMJ. 2001; 322: 1511-1516
        • Hale M.
        • Speight K.
        • Harsanyi Z.
        • Iwan T.
        • Slagle N.
        • Lacouture P.
        • Darke A.
        Efficacy of 12 hourly controlled-release codeine compared with as required dosing of acetaminophen plus codeine in patients with chronic low back pain.
        Pain Res Manag. 1997; 2: 33-38
        • Hale M.E.
        • Dvergsten C.
        • Gimbel J.
        Efficacy and safety of oxymorphone extended release in chronic low back pain: Results of a randomized, double-blind, placebo- and active-controlled phase III study.
        J Pain. 2005; 6: 21-28
        • Harris R.P.
        • Helfand M.
        • Woolf S.H.
        • Lohr K.N.
        • Mulrow C.D.
        • Teutsch S.M.
        • Atkins D.
        Current methods of the third US Preventive Services Task Force.
        Am J Prev Med. 2001; 20: 21-35
        • Hartung D.M.
        • Middleton L.
        • Haxby D.G.
        • Koder M.
        • Ketchum K.L.
        • Chou R.
        Rates of adverse events of long-acting opioids in a state Medicaid program.
        Ann Pharmacother. 2007; 41: 921-928
        • Hays H.
        Use of methadone in treating chronic noncancer pain.
        Pain Res Manag. 1999; 4: 23-27
        • Hoffman B.M.
        • Chatkoff D.K.
        • Papas R.K.
        • Kerns R.D.
        Meta-analysis of psychological interventions for chronic low back pain.
        Health Psychol. 2007; 26: 1-9
        • Hojsted J.
        • Sjogren P.
        Addiction to opioids in chronic pain patients: A literature review.
        Eur J Pain. 2007; 11: 490-518
        • Hollingshead J.
        • Duhmke R.
        • Cornblath D.
        Tramadol for neuropathic pain.
        Cochrane Database Syst Rev. 2006; (CD003726)
        • Holmes C.P.
        • Gatchel R.J.
        • Adams L.L.
        • Stowell A.W.
        • Hatten A.
        • Noe C.
        • Lou L.
        An opioid screening instrument: Long-term evaluation of the utility of the Pain Medication Questionnaire.
        Pain Pract. 2006; 6: 74-88
        • Huse E.
        • Larbig W.
        • Flor H.
        • Birbaumer N.
        The effect of opioids on phantom limb pain and cortical reorganization.
        Pain. 2001; 90: 47-55
        • Jadad A.R.
        • McQuay H.J.
        Meta-analyses to evaluate analgesic interventions: A systematic qualitative review of their methodology.
        J Clin Epidemiol. 1996; 49: 235-243
        • Jadad A.R.
        • Moore R.A.
        • Carroll D.
        • Jenkinson C.
        • Reynolds D.J.
        • Gavaghan D.J.
        • McQuay H.J.
        Assessing the quality of reports of randomized clinical trials: Is blinding necessary?.
        Control Clin Trials. 1996; 17: 1-12
        • Jamison R.N.
        • Raymond S.A.
        • Slawsby E.A.
        • Nedeljkovic S.S.
        • Katz N.P.
        Opioid therapy for chronic noncancer back pain: A randomized prospective study.
        Spine. 1998; 23: 2591-2600
      4. Johnson M, Mortimer S, Bogle S, Hallam SJ. A study to compare subject acceptability of Duragesic with sustained release morphine in subjects requiring strong opioids for chronic non-malignant pain. Available at: http://www.janssen-cilag.com/content/backgrounders/janssen-cilag.com/SynopsisFEN-GBR-21.pdf. Accessed May 29, 2007

        • Jovey R.D.
        • Ennis J.
        • Gardner-Nix J.
        • Goldman B.
        • Hays H.
        • Lynch M.
        • Moulin D.
        Use of opioid analgesics for the treatment of chronic noncancer pain: A consensus statement and guidelines from the Canadian Pain Society, 2002.
        Pain Res Manag. 2003; 8: 3A-28A
        • Kalso E.
        • Allan L.
        • Dellemijn P.L.
        • Faura C.C.
        • Ilias W.K.
        • Jensen T.S.
        • Perrot S.
        • Plaghki L.H.
        • Zenz M.
        European Federation of Chapters of the International Association for the Study of Pain: Recommendations for using opioids in chronic non-cancer pain.
        Eur J Pain. 2003; 7: 381-386
        • Kalso E.
        • Edwards J.E.
        • Moore R.A.
        • McQuay H.J.
        Opioids in chronic non-cancer pain: Systematic review of efficacy and safety.
        Pain. 2004; 112: 372-380
        • Kalso E.
        • Simpson K.H.
        • Slappendel R.
        • Dejonckheere J.
        • Richarz U.
        Predicting long-term response to strong opioids in patients with low back pain: Findings from a randomized, controlled trial of transdermal fentanyl and morphine.
        BMC Med. 2007; 5: 39
        • Karjalainen K.
        • Malmivaara A.
        • van Tulder M.W.
        • Roine R.
        • Jauhiainen M.
        • Hurri H.
        • Koes B.
        Multidisciplinary biopsychosocial rehabilitation for subacute low back pain in working-age adults: A systematic review within the framework of the Cochrane Collaboration Back RevIew Group.
        Spine. 2001; 26: 262-269
        • Krantz M.J.
        • Lewkowiez L.
        • Hays H.
        • Woodroffe M.A.
        • Robertson A.D.
        • Mehler P.S.
        Torsade de pointes associated with very-high-dose methadone.
        Ann Intern Med. 2002; 137: 501-504
        • Lijmer J.G.
        • Mol B.W.
        • Heisterkamp S.
        • Bonsel G.J.
        • Prins M.H.
        • van der Meulen J.H.
        • Bossuyt P.M.
        Empirical evidence of design-related bias in studies of diagnostic tests.
        JAMA. 1999; 282: 1061-1066
        • Maier C.
        • Hildebrandt J.
        • Klinger R.
        • Henrich-Eberl C.
        • Lindena G.
        Morphine responsiveness, efficacy and tolerability in patients with chronic non-tumor associated pain: Results of a double-blind placebo-controlled trial (MONTAS).
        Pain. 2002; 97: 223-233
        • Manchikanti L.
        • Pampati V.
        • Damron K.S.
        • McManus C.D.
        Evaluation of variables in illicit drug use: does a controlled substance abuse screening tool identify illicit drug use?.
        Pain Physician. 2004; 7: 71-75
        • Martell B.
        Systematic review: Opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction.
        Ann Intern Med. 2007; 146: 116-127
        • Matsumoto A.K.
        • Babul N.
        • Ahdieh H.
        Oxymorphone extended-release tablets relieve moderate to severe pain and improve physical function in osteoarthritis: Results of a randomized, double-blind, placebo- and active-controlled phase III trial.
        Pain Med. 2005; 6: 357-366
        • McCracken L.M.
        • Turk D.C.
        Behavioral and cognitive-behavioral treatment for chronic pain: Outcome, predictors of outcome, and treatment process.
        Spine. 2002; 27: 2564-2573
        • McGinn T.G.
        • Guyatt G.H.
        • Wyer P.C.
        • Naylor C.D.
        • Stiell I.G.
        • Richardson W.S.
        Users' guides to the medical literature XXII: How to use articles about clinical decision rules.
        JAMA. 2000; 284: 79-84
        • McNicol E.
        • Horowicz-Mehler N.
        • Fisk R.A.
        • Bennett K.
        • Gialeli-Goudas M.
        • Chew P.W.
        • Lau J.
        • Carr D.
        Management of opioid side effects in cancer-related and chronic noncancer pain: A systematic review.
        J Pain. 2003; 4: 231-256
        • McNicol E.D.
        • Boyce D.
        • Schumann R.
        • Carr D.B.
        Mu-opioid antagonists for opioid-induced bowel dysfunction.
        Cochrane Database Syst Rev. 2008; (CD006332)
        • Menefee L.A.
        • Frank E.D.
        • Crerand C.
        • Jalali S.
        • Park J.
        • Sanschagrin K.
        • Besser M.
        The effects of transdermal fentanyl on driving, cognitive performance, and balance in patients with chronic nonmalignant pain conditions.
        Pain Med. 2004; 5: 42-49
        • Mercadante S.
        • Arcuri E.
        • Fusco F.
        • Tirelli W.
        • Villari P.
        • Bussolino C.
        • Campa T.
        • Conno F.
        • Ripamonti C.
        Randomized double-blind, double-dummy crossover clinical trial of oral tramadol versus rectal tramadol administration in opioid-naive cancer patients with pain.
        Support Care Cancer. 2005; 13: 702-707
        • Mercadante S.
        • Portenoy R.K.
        Opioid poorly-responsive cancer pain, 1: Clinical considerations.
        J Pain Symptom Manage. 2001; 21: 144-150
        • Michna E.
        • Ross E.L.
        • Hynes W.L.
        • Nedeljkovic S.S.
        • Soumekh S.
        • Janfaza D.
        • Palombi D.
        • Jamison R.N.
        Predicting aberrant drug behavior in patients treated for chronic pain: importance of abuse history.
        J Pain Symptom Manage. 2004; 28: 250-258
        • Moher D.
        • Pham B.
        • Klassen T.P.
        • Schulz K.F.
        • Berlin J.A.
        • Jadad A.R.
        • Liberati A.
        What contributions do languages other than English make on the results of meta-analyses?.
        J Clin Epidemiol. 2000; 53: 964-972
        • Moore R.A.
        • McQuay H.J.
        Prevalence of opioid adverse events in chronic non-malignant pain: Systematic review of randomised trials of oral opioids.
        Arthritis Res Ther. 2005; 7: R1046-R1051
        • Morley J.S.
        • Bridson J.
        • Nash T.P.
        • Miles J.B.
        • White S.
        • Makin M.K.
        Low-dose methadone has an analgesic effect in neuropathic pain: A double-blind randomized controlled crossover trial.
        Palliat Med. 2003; 17: 576-587
        • Morley S.
        • Eccleston C.
        • Williams A.
        Systematic review and meta-analysis of randomized controlled trials of cognitive behaviour therapy and behaviour therapy for chronic pain in adults, excluding headache.
        Pain. 1999; 80: 1-13
        • Nicholson B.
        • Ross E.
        • Weil A.
        • Sasaki J.
        • Sacks G.
        Treatment of chronic moderate-to-severe non-malignant pain with polymer-coated extended-release morphine sulfate capsules.
        Curr Med Res Opin. 2006; 22: 539-550
        • Niemann T.
        • Madsen L.G.
        • Larsen S.
        • Thorsgaard N.
        Opioid treatment of painful chronic pancreatitis: Transdermal fentanyl versus sustained-release morphine.
        Int J Pancreatol. 2000; 27: 235-240
        • Noble M.
        • Tregear S.J.
        • Treadwell J.R.
        • Schoelles K.
        Long-term opioid therapy for chronic noncancer pain: A systematic review and meta-analysis of efficacy and safety.
        J Pain Symptom Manage. 2008; 35: 214-228
        • Olsen Y.
        • Daumit G.L.
        • Ford D.E.
        Opioid prescriptions by US primary care physicians from 1992 to 2001.
        J Pain. 2006; 7: 225-235
        • Oregon Department of Human Services
        Methadone deaths (and distribution) on the rise.
        CD Summary. 2003; 52
        • Ostelo R.W.
        • van Tulder M.W.
        • Vlaeyen J.W.
        • Linton S.J.
        • Morley S.J.
        • Assendelft W.J.
        Behavioural treatment for chronic low-back pain.
        Cochrane Database of Syst Rev. 2005; (CD002014)
        • Oxman A.D.
        • Guyatt G.H.
        Validation of an index of the quality of review articles.
        J Clin Epidemiol. 1991; 44: 1271-1278
        • Paulson D.M.
        • Kennedy D.T.
        • Donovick R.A.
        • Carpenter R.L.
        • Cherubini M.
        • Techner L.
        • Du W.
        • Ma Y.
        • Schmidt W.K.
        • Wallin B.
        • Jackson D.
        Alvimopan: An oral, peripherally acting, mu-opioid receptor antagonist for the treatment of opioid-induced bowel dysfunction-a 21-day treatment-randomized clinical trial.
        J Pain. 2005; 6: 184-192
        • Peters J.
        • Large R.G.
        • Elkind G.
        Follow-up results from a randomised controlled trial evaluating in- and outpatient pain management programmes.
        Pain. 1992; 50: 41-50
        • Petrone D.
        • Kamin M.
        • Olson W.
        Slowing the titration rate of tramadol HCl reduces the incidence of discontinuation due to nausea and/or vomiting: A double-blind randomized trial.
        J Clin Pharm Ther. 1999; 24: 115-123
        • Portenoy R.
        Fentanyl buccal tablet (FBT) for relief of breakthrough pain in opioid-treated patients with chronic low back pain: a randomized, placebo-controlled study.
        Curr Med Res Opin. 2007; 23: 223-233
        • Portenoy R.
        • Farrar J.
        • Backonja M.
        • Cleeland C.
        • Yang K.
        • Friedman M.
        • Colucci S.
        • Richards P.
        Long-term use of controlled-release oxycodone for noncancer pain: Results of a 3-year registry study.
        Clin J Pain. 2007; 23: 287-299
        • Portenoy R.K.
        • Thomas J.
        • Boatwright M.L.M.B.
        • Tran D.
        • Galasso F.L.
        • Stambler N.
        • Von Gunten C.F.
        • Israel R.J.
        Subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness: A double-blind, randomized, parallel group, dose-ranging study.
        J Pain Symptom Manage. 2008; 35: 458-468
        • Quang-Cantagrel N.D.
        • Wallace M.S.
        • Magnuson S.K.
        Opioid substitution to improve the effectiveness of chronic noncancer pain control: A chart review.
        Anesth Analg. 2000; 90: 933-937
        • Raja S.N.
        • Haythornthwaite J.A.
        • Pappagallo M.
        • Clark M.R.
        • Travison T.G.
        • Sabeen S.
        • Royall R.M.
        • Max M.B.
        Opioids versus antidepressants in postherpetic neuralgia: A randomized, placebo-controlled trial.
        Neurology. 2003; 59: 1015-1021
        • Ralphs J.A.
        • Williams A.C.
        • Richardson P.H.
        • Pither C.E.
        • Nicholas M.K.
        Opiate reduction in chronic pain patients: A comparison of patient-controlled reduction and staff controlled cocktail methods.
        Pain. 1994; 56: 279-288
        • Rauck R.L.
        The ACTION study: A randomized, open-label, multicenter trial comparing once-a-day extended-release morphine sulfate capsules (AVINZA) to twice-a-day controlled-release oxycodone hydrochloride tablets (OxyContin) for the treatment of chronic, moderate to severe low back pain.
        J Opioid Manag. 2006; 2: 155-166
        • Rauck R.L.
        A randomized, open-label, multicenter trial comparing once-a-day AVINZA (morphine sulfate extended-release capsules) versus twice-a-day OxyContin (oxycodone hydrochloride controlled-released tablets) for the treatment of chronic, moderate to severe low back pain: Improved physical functioning in the ACTION trial.
        J Opioid Manag. 2007; 3: 35-43
        • Ruoff G.E.
        Slowing the initial titration rate of tramadol improves tolerability.
        Pharmacotherapy. 1999; 19: 88-93
        • Sabatowski R.
        • Schwalen S.
        • Rettig K.
        • Herberg K.W.
        • Kasper S.M.
        • Radbruch L.
        Driving ability under long-term treatment with transdermal fentanyl.
        J Pain Symptom Manage. 2003; 25: 38-47
        • Salzman R.T.
        • Brobyn R.D.
        Long-term comparison of suprofen and propoxyphene in patients with osteoarthritis.
        Pharmacology. 1983; 27: 55-64
        • Salzman R.T.
        • Roberts M.S.
        • Wild J.
        • Fabian C.
        • Reder R.F.
        • Goldenheim P.D.
        Can a controlled release oral dose form of oxycodone be used as readily as an immediate release form for the purpose of titrating to stable pain control?.
        J Pain Symptom Manage. 1999; 18: 271-279
        • Sandoval J.A.
        • Furlan A.D.
        • Mailis-Gagnon A.
        Oral methadone for chronic noncancer pain: A systematic literature review of reasons for administration, prescription patterns, effectiveness, and side effects.
        Clin J Pain. 2005; 21: 503-512
        • Saper J.R.
        • Lake 3rd, A.E.
        • Hamel R.L.
        • Lutz T.E.
        • Branca B.
        • Sims D.B.
        • Kroll M.M.
        Daily scheduled opioids for intractable head pain: Long-term observations of a treatment program.
        Neurology. 2004; 62: 1687-1694
        • Schonstein E.
        • Kenny D.T.
        • Keating J.
        • Koes B.W.
        Work conditioning, work hardening and functional restoration for workers with back and neck pain.
        Cochrane Database Syst Rev. 2003; (CD001822)
        • Sigler K.
        Effect of a triplicate prescription law on prescribing of Schedule II drugs.
        Am J Hosp Pharm. 1984; 41: 108-111
        • Simpson D.M.
        • Messina J.
        • Xie F.
        • Hale M.
        Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: A multicenter, randomized, double-blind, placebo-controlled study.
        Clin Ther. 2007; 29: 588-601
        • Staats P.S.
        • Markowitz J.
        • Schein J.
        Incidence of constipation associated with long-acting opioid therapy: A comparative study.
        South Med J. 2004; 97: 129-134
        • Stewart W.F.
        • Ricci J.A.
        • Chee E.
        • Morganstein D.
        • Lipton R.
        Lost productive time and cost due to common pain conditions in the US workforce.
        JAMA. 2003; 290: 2443-2454
        • Takkouche B.
        • Montes-Martinez A.
        • Gill S.S.
        • Etminam M.
        Psychotropic medications and the risk of fracture: A meta-analysis.
        Drug Saf. 2007; 30: 171-184
        • Tennant Jr, F.S.
        • Rawson R.A.
        • Miranda L.
        • Obert J.
        Outpatient treatment of prescription opioid dependence: Comparison of two methods.
        NIDA Res Monogr. 1983; 43: 315-321
        • Management of Opioid Therapy for Chronic Pain Working Group
        VA/DoD Clinical Practical Guidelines for the management of opioid therapy for chronic pain.
        Contract Number. 2003; (V101(93)P-1633(version 1.0))
        • Thomas J.A.
        • Karver S.
        • Cooney G.A.
        • Chamberlain B.H.
        • Watt C.K.
        • Slatkin N.E.
        • Stambler N.
        • Kremer A.B.
        • Israel R.J.
        Methylnaltrexone for opioid-induced constipation in advanced illness.
        N Engl J Med. 2008; 358: 2332-2343
        • Thomsen A.B.
        • Becker N.
        • Eriksen J.
        Opioid rotation in chronic non-malignant pain patients: A retrospective study.
        Acta Anaesth Scand. 1999; 43: 918-923
        • Toma M.
        • McAlister F.A.
        • Bialy L.
        • Adams D.B.
        • Vandermeer B.
        • Armstrong P.W.
        Transition from meeting abstract to full-length journal article for randomized controlled trials.
        JAMA. 2006; 295: 1281-1287
        • Trescot A.M.
        • Boswell M.V.
        • Atluri S.L.
        • Hansen H.C.
        • Deer T.R.
        • Abdi S.
        • Jasper J.F.
        • Singh V.
        • Jordan A.E.
        • Johnson B.W.
        • Cicala R.S.
        • Dunbar E.E.
        • Helm 2nd, S.
        • Varley K.G.
        • Suchdev P.K.
        • Swicegood J.R.
        • Calodney A.K.
        • Ogoke B.A.
        • Minore W.S.
        • Manchikanti L.
        Opioid guidelines in the management of chronic non-cancer pain.
        Pain Physician. 2006; 9: 1-39
      5. United States General Accounting Office (GAO): Prescription drugs: State monitoring programs provide useful tool to reduce diversion. Report to the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives: May 17, 2002

        • van Tulder M.
        • Furlan A.D.
        • Bombardier C.
        • Bouter L.
        The Editorial Board of the Cochrane Collaboration Back Review Group: Updated method guidelines for systematic reviews in the Cochrane Collaboration Back Review Group.
        Spine. 2003; 28: 1290-1299
        • van Tulder M.W.
        • Vlaeyen J.W.
        • Linton S.J.
        • Morley S.J.
        • Assendelft W.J.
        Behavioral treatment for chronic low back pain.
        Cochrane Database of Syst Rev. 2005; (CD002014)
        • Verhaak P.F.
        • Kerssens J.J.
        • Dekker J.
        • Sorbi M.J.
        • Bensing J.M.
        Prevalence of chronic benign pain disorder among adults: A review of the literature.
        Pain. 1998; 77: 231-239
        • Wasan A.D.
        • Butler S.F.
        • Budman S.H.
        • Benoit C.
        • Fernandez K.
        • Jamison R.N.
        Psychiatric history and psychologic adjustment as risk factors for aberrant drug-related behavior among patients with chronic pain.
        Clin J Pain. 2007; 23: 307-315
        • Wastila L.
        The influence of multiple copy prescription programs on analgesic utilization.
        J Pharm Care Pain Symp Cont. 1996; 4: 3-19
        • Webster L.R.
        • Butera P.G.
        • Moran L.V.
        • Wu N.
        • Burns L.H.
        • Friedmann N.
        Oxytrex minimizes physical dependence while providing effective analgesia: A randomized controlled trial in low back pain.
        J Pain. 2006; 7: 937-946
        • Webster L.
        • Jansen J.P.
        • Peppin J.
        • Lasko B.
        • Irving G.
        • Morlion B.
        • Snidow J.
        • Pierce A.
        • Mortensen E.
        • Kleoudis C.
        • Carteret E.
        Alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioid-included bowel dysfunction: Results from a randomized, double-blind, placebo-controlled, dose-finding study in subjects taking opioids for chronic non-cancer pain.
        Pain. 2008; 137: 428-440
        • Webster L.R.
        • Webster R.M.
        Predicting aberrant behaviors in opioid-treated patients: Preliminary validation of the Opioid Risk Tool.
        Pain Med. 2005; 6: 432-442
        • Whiting P.
        • Rutjes A.
        • Reitsma J.
        • Glas A.
        • Bossuyt P.
        • Kleijnen J.
        Sources of variation and bias in studies of diagnostic accuracy: a systematic review.
        Ann Intern Med. 2004; 140: 189-202
        • Wiedemer N.L.
        • Harden P.S.
        • Arndt I.O.
        • Gallagher R.M.
        The opioid renewal clinic: A primary care, managed approach to opioid therapy in chronic pain patients at risk for substance abuse.
        Pain Med. 2007; 8: 573-584
        • Wu S.M.
        • Compton P.
        • Bolus R.
        • Schieffer B.
        • Pham Q.
        • Baria A.
        • Van Vort W.
        • Davis F.
        • Shekelle P.
        • Naliboff B.D.
        The Addiction Behaviors Checklist: Validation of a new clinician-based measure of inappropriate opioid use in chronic pain.
        J Pain Symptom Manage. 2006; 32: 342-351